scholarly article | Q13442814 |
P50 | author | Pierre Corvol | Q3384528 |
Jean-Marc Lalouel | Q67189879 | ||
Xavier Jeunemaitre | Q30225352 | ||
P2093 | author name string | C Williams | |
A M Sharma | |||
A Hata | |||
M Powers | |||
I Inoue | |||
A Charru | |||
J Tichet | |||
A P Gimenez-Roqueplo | |||
P2860 | cites work | Angiotensinogen: a candidate gene involved in preeclampsia? | Q54968097 |
Linkage of the Angiotensinogen Gene to Essential Hypertension | Q57282024 | ||
Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese | Q58363984 | ||
Role of angiotensinogen in blood pressure homeostasis | Q70310779 | ||
The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein | Q71058900 | ||
Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset | Q71525725 | ||
Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibody-based immunoanalysis | Q71652224 | ||
Detection and characterization of new mutations in the human angiotensinogen gene (AGT) | Q71867084 | ||
Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study | Q71922816 | ||
Angiotensinogen gene and blood pressure in the Japanese population | Q72166716 | ||
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease | Q72318715 | ||
M235T variant of the human angiotensinogen gene in unselected hypertensive patients | Q72364664 | ||
Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis | Q72533083 | ||
Cross-sectional analysis of Met235-->Thr variant of angiotensinogen gene in severe, familial hypertension | Q72673485 | ||
A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate | Q72791693 | ||
Angiotensinogen Met235-->Thr polymorphism in a London normotensive and hypertensive black and white population | Q72880520 | ||
A molecular variant of angiotensinogen associated with preeclampsia | Q24309422 | ||
Kinetics of the human renin and human substrate reaction | Q28115887 | ||
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms | Q28256462 | ||
Paleolithic nutrition. A consideration of its nature and current implications | Q34048501 | ||
Angiotensinogen as a risk factor for essential hypertension in Japan | Q34133604 | ||
Genetic control of blood pressure and the angiotensinogen locus | Q34498129 | ||
High-resolution linkage mapping for susceptibility genes in human polygenic disease: insulin-dependent diabetes mellitus and chromosome 11q. | Q35196545 | ||
The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes | Q35246352 | ||
The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children | Q35552198 | ||
Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans | Q35751908 | ||
Structure of human angiotensinogen gene | Q36417768 | ||
Short report: HYPERGENE: a clinical and genetic database for genetic analysis of human hypertension. | Q36711607 | ||
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro | Q37365783 | ||
A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene. | Q38301345 | ||
A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene | Q38355631 | ||
The effect of increased salt intake on blood pressure of chimpanzees | Q39368949 | ||
Assessment of nutritional correlates of blood pressure | Q40270868 | ||
Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection | Q40408816 | ||
The molecular basis for phenotypic diversity of genetic disease. | Q40454365 | ||
Dinucleotide repeat polymorphism in the human angiotensinogen gene | Q40509841 | ||
Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis | Q40986535 | ||
Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects | Q41199815 | ||
Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota | Q44046291 | ||
Angiotensinogen: an attractive and underrated participant in hypertension and inflammation | Q44624581 | ||
Molecular basis of human hypertension: role of angiotensinogen | Q45118696 | ||
Evolution and distribution of (GT)n repetitive sequences in mammalian genomes | Q46113696 | ||
Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans | Q46590314 | ||
Lessons from a "Primitive" People | Q47746148 | ||
A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system | Q48073728 | ||
Identification of cell type-dependent enhancer core element located in the 3'-downstream region of the human angiotensinogen gene. | Q48077945 | ||
Effect of the angiotensinogen gene Met235-->Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations | Q53835841 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | essential hypertension | Q988405 |
P304 | page(s) | 1448-1460 | |
P577 | publication date | 1997-06-01 | |
P1433 | published in | American Journal of Human Genetics | Q4744249 |
P1476 | title | Haplotypes of angiotensinogen in essential hypertension | |
P478 | volume | 60 |
Q51542524 | A genealogical study of essential hypertension with and without obesity in French Canadians. |
Q42807788 | A haplotype of angiotensinogen gene that is associated with essential hypertension increases its promoter activity in adipocytes |
Q53098465 | AGT M235T polymorphism contributes to risk of preeclampsia: evidence from a meta-analysis. |
Q44762843 | AGT and RH blood group polymorphisms affect blood pressure and lipids in Afro-Caribbeans |
Q84098505 | AGT genetic variation, plasma AGT, and blood pressure: An analysis of the Utah Genetic Reference Project pedigrees |
Q36453507 | Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice |
Q37130291 | Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects |
Q47137535 | Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease |
Q35916436 | Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans. |
Q36622923 | Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy |
Q73235838 | Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes |
Q47690856 | Angiotensinogen gene polymorphism predicts hypertension, and iridological constitutional classification enhances the risk for hypertension in Koreans |
Q35766650 | Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts |
Q60704850 | Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue |
Q33917325 | Angiotensinogen variants and human hypertension |
Q34291477 | Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system |
Q35756376 | Association between angiotensinogen M235T polymorphism and hypertrophic cardiomyopathy |
Q46952825 | Association between evolutionary history of angiotensinogen haplotypes and plasma levels |
Q43746658 | Association between the M268T polymorphism in the angiotensinogen gene and essential hypertension in a South Indian population. |
Q37726913 | Association of angiotensinogen gene SNPs and haplotypes with risk of hypertension in eastern Indian population |
Q80675009 | Association of novel promoter single nucleotide polymorphisms in vasopressin V1a receptor gene with essential hypertension in nonobese Japanese |
Q39972387 | Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects |
Q38977861 | Association of the angiotensinogen M235T polymorphism with recurrence after catheter ablation of acquired atrial fibrillation |
Q54771310 | Association of two angiotensinogen gene polymorphisms, M235T and G(-6)A, with chronic heart failure. |
Q43447307 | Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population |
Q77762487 | Blood pressure and the T174M and M235T polymorphisms of the angiotensinogen gene |
Q34222317 | Cardiovascular Consequences of Genetic Variation at −6/235 in Human Angiotensinogen Using “Humanized” Gene-Targeted Mice |
Q43235395 | Changes in angiotensin type 1 receptor binding and angiotensin-induced pressor responses in the rostral ventrolateral medulla of angiotensinogen knockout mice |
Q36177892 | Comparative clinical science: The medicine of the future |
Q51986656 | Context-dependency of the relation between left ventricular mass and AGT gene variants. |
Q56893651 | Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis |
Q85193153 | Difference in Angiotensinogen Haplotype Frequencies Between Chronic Heart Failure and Advanced Atherosclerosis Patients – New Prognostic Factor? |
Q90327973 | Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure |
Q37178621 | Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study |
Q28083698 | Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited |
Q22306391 | Essential Hypertension : Part I: Definition and Etiology |
Q44095530 | Essential arterial hypertension and polymorphism of angiotensinogen M235T gene. |
Q47375806 | Evaluation of TNF-alpha and IL-1beta polymorphisms in Taiwan Chinese patients with pterygium |
Q34064093 | From genetics to mechanism of disease liability |
Q28215488 | Genetic basis of cardiovascular disease--the renin-angiotensin-aldosterone system as a paradigm |
Q24538960 | Genetic mapping of ossification of the posterior longitudinal ligament of the spine |
Q33416406 | Genetic polymorphisms and the risk of accelerated renal function decline in women |
Q34116575 | Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease |
Q35708128 | Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches |
Q36722035 | Genetics of arterial hypertension and hypotension |
Q38334263 | Genetics of hypertension. Therapeutic implications |
Q34515156 | Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes |
Q38418095 | Genotyping the -6A/G functional polymorphism in the core promoter region of angiotensinogen gene by microchip electrophoresis. |
Q34030867 | Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension. |
Q64948559 | Hypertension and Cerebral Microangiopathy (Cerebral Small Vessel Disease): Genetic and Epigenetic Aspects of Their Relationship. |
Q37867324 | Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy |
Q34028121 | Linkage mapping for hypertension susceptibility genes |
Q36079020 | Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases |
Q38793780 | Molecular genetics of essential hypertension |
Q34049233 | Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration |
Q46352120 | Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic |
Q37360005 | Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations |
Q40695929 | Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. |
Q77225219 | Polymorphisms in angiotensinogen gene (M235T and G(-6)A) in multifactorial diseases |
Q57253889 | Polymorphisms in the angiotensinogen gene are associated with carotid intimal–medial thickening in females from a community-based population |
Q34477685 | Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage |
Q46833472 | Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study |
Q46308918 | Quantification of intact plasma AGT consisting of oxidized and reduced conformations using a modified ELISA. |
Q84979204 | Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS) |
Q37097939 | Renin-angiotensin system genes and exercise training-induced changes in sodium excretion in African American hypertensives. |
Q46819030 | Renin-angiotensin-aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients |
Q51164006 | Risk conferred by tagged SNPs of AGT gene in causing susceptibility to essential hypertension. |
Q40658647 | Role of tagged SNPs of the AGT gene in causing susceptibility to essential hypertension |
Q45041470 | Role of two angiotensinogen polymorphisms in blood pressure variation |
Q36822241 | STK39 and WNK1 Are Potential Hypertension Susceptibility Genes in the BELHYPGEN Cohort |
Q39374023 | Simple renal cysts and hypertension are associated with angiotensinogen (AGT) gene variant in Shiraz population (Iran). |
Q34081504 | Single nucleotide polymorphisms and the future of genetic epidemiology |
Q30235938 | The Hypertension Pandemic: An Evolutionary Perspective |
Q35046402 | The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach |
Q54391063 | The associations between maternal and fetal angiotensinogen M235T polymorphism and pregnancy-induced hypertension in Chinese women. |
Q27002339 | The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy |
Q92625634 | The relationship among angiotensinogen genes polymorphisms and hs-CRP and coronary artery disease |
Q43988961 | The relationship between angiotensinogen gene polymorphisms and essential hypertension in a Northern Han Chinese population |
Q52966124 | The renin-angiotensin system in obesity hypertension. |
Q34572777 | The role of angiotensin II in cognition and behaviour |
Q40588847 | Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis |
Q33610174 | Transcriptional regulation of angiotensinogen gene expression. |
Q35461116 | Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population |
Q73540804 | [Role of the angiotensinogen gene for essential hypertension] |
Q43800742 | alpha-Adducin gene and essential hypertension in China |
Search more.